Annual Current Liabilities
$25.89 M
+$16.18 M+166.54%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual total current liabilities is $25.89 million, with the most recent change of +$16.18 million (+166.54%) on December 31, 2023.
- During the last 3 years, ELVN annual current liabilities has risen by +$24.42 million (+1651.96%).
- ELVN annual current liabilities is now at all-time high.
Performance
ELVN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$17.03 M
-$5.08 M-22.97%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly total current liabilities is $17.03 million, with the most recent change of -$5.08 million (-22.97%) on September 30, 2024.
- Over the past year, ELVN quarterly current liabilities has dropped by -$8.00 million (-31.98%).
- ELVN quarterly current liabilities is now -34.24% below its all-time high of $25.89 million, reached on December 31, 2023.
Performance
ELVN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ELVN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.5% | -32.0% |
| 3 y3 years | +1652.0% | +55.6% |
| 5 y5 years | +1652.0% | +55.6% |
ELVN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +350.1% | -34.2% | +196.0% |
| 5 y | 5-year | at high | +1652.0% | -34.2% | +196.0% |
| alltime | all time | at high | +1652.0% | -34.2% | +196.0% |
Enliven Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.03 M(-23.0%) |
| Jun 2024 | - | $22.11 M(-11.7%) |
| Mar 2024 | - | $25.03 M(-3.3%) |
| Dec 2023 | $25.89 M | $25.89 M(+114.4%) |
| Sep 2023 | - | $12.08 M(+32.1%) |
| Jun 2023 | - | $9.15 M(-16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $10.94 M(+12.6%) |
| Dec 2022 | $9.71 M(+68.9%) | $9.71 M(+16.6%) |
| Sep 2022 | - | $8.33 M(+44.8%) |
| Dec 2021 | $5.75 M(+289.2%) | - |
| Dec 2021 | - | $5.75 M |
| Dec 2020 | $1.48 M | - |
FAQ
- What is Enliven Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics annual current liabilities year-on-year change?
- What is Enliven Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly current liabilities year-on-year change?
What is Enliven Therapeutics annual total current liabilities?
The current annual current liabilities of ELVN is $25.89 M
What is the all time high annual current liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high annual total current liabilities is $25.89 M
What is Enliven Therapeutics annual current liabilities year-on-year change?
Over the past year, ELVN annual total current liabilities has changed by +$16.18 M (+166.54%)
What is Enliven Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ELVN is $17.03 M
What is the all time high quarterly current liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly total current liabilities is $25.89 M
What is Enliven Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ELVN quarterly total current liabilities has changed by -$8.00 M (-31.98%)